| scholarly article | Q13442814 |
| P2093 | author name string | Cheang M | |
| Gough J | |||
| McKenna R | |||
| Jeffery J | |||
| Rush D | |||
| Solez K | |||
| Grimm P | |||
| Nickerson P | |||
| Trpkov K | |||
| P433 | issue | 11 | |
| P304 | page(s) | 2129-2134 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Beneficial effects of treatment of early subclinical rejection: a randomized study | |
| P478 | volume | 9 |
| Q41946081 | Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis |
| Q34204497 | An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis |
| Q47773036 | Antibody-mediated rejection in young kidney transplant recipients: the dilemma of noncompliance and insufficient immunosuppression |
| Q42395013 | Begin at the Beginning to Prevent the End. |
| Q88564139 | Benefits and risks of protocol biopsies in pediatric renal transplantation |
| Q36445529 | Chronic allograft injury by subclinical borderline change: evidence from serial protocol biopsies in kidney transplantation |
| Q61877210 | Chronic allograft nephropathy |
| Q36582300 | Chronic allograft nephropathy in paediatric renal transplantation |
| Q35929301 | Chronic progressive calcineurin nephrotoxicity: an overstated concept |
| Q92670695 | Clinical Significance of Renal Allograft Protocol Biopsies: A Single Tertiary Center Experience in Malaysia |
| Q36062030 | Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens |
| Q36029287 | Corticosteroid avoidance in pediatric renal transplantation |
| Q35902393 | Corticosteroid avoidance in pediatric renal transplantation: can it be achieved? |
| Q28748866 | Deconvoluting post-transplant immunity: cell subset-specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cells |
| Q36105785 | Decreased Kidney Graft Survival in Low Immunological Risk Patients Showing Inflammation in Normal Protocol Biopsies. |
| Q73086224 | Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection |
| Q38569092 | Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection. |
| Q40947453 | Early subclinical rejection treated with low dose i.v. steroids is not associated to graft survival impairment: 13-years' experience at a single center. |
| Q90418562 | Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejection |
| Q34457101 | Fibrosis with inflammation at one year predicts transplant functional decline. |
| Q39035802 | Kidney Fibrosis: Origins and Interventions |
| Q24675073 | Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes |
| Q52683630 | Long-term results of protocol kidney biopsy directing steroid withdrawal in simultaneous pancreas-kidney transplant patients. |
| Q90428781 | Low-dose Rituximab and Thymoglobulin Induction With Steroid-free Maintenance Immunosuppression and Protocol Biopsies Improves Long-term Patient and Graft Survival After Kidney Transplantation: Survival and Safety Outcomes in More Than 1100 Patients |
| Q64053896 | Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients |
| Q33793521 | Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples |
| Q33793437 | Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. |
| Q47577521 | Non-invasive evaluation of stable renal allograft function using point shear-wave elastography |
| Q34503698 | Novel diagnostics in renal transplantation |
| Q37243068 | Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation |
| Q90282166 | Observer variability in the assessment of renal 18F-FDG uptake in kidney transplant recipients |
| Q38966321 | Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform. |
| Q41676628 | Plasma microRNAs Are Potential Biomarkers of Acute Rejection After Hindlimb Transplantation in Rats |
| Q52783253 | Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. |
| Q50322455 | Practice Patterns in the Treatment and Monitoring of Acute T Cell-Mediated Kidney Graft Rejection in Canada. |
| Q92469050 | Prediction of renal allograft chronic rejection using a model based on contrast-enhanced ultrasonography |
| Q36906015 | Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. |
| Q46960861 | Progression of Interstitial Fibrosis in Kidney Transplantation |
| Q26751478 | Proteomics for rejection diagnosis in renal transplant patients: Where are we now? |
| Q47945773 | Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression |
| Q89450524 | Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management |
| Q42378146 | Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients |
| Q36465981 | Rationale and design of the RIACT-study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a |
| Q36929501 | Renal transplant rejection markers |
| Q93269609 | Serial Peripheral Blood Gene Expression Profiling to Assess Immune Quiescence in Kidney Transplant Recipients with Stable Renal Function |
| Q35790552 | Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts |
| Q41790517 | Subclinical rejection in renal transplants is associated with low serum mannose-binding lectin levels |
| Q38225882 | The Interplay between inflammation and fibrosis in kidney transplantation. |
| Q36132592 | The impact of age on rejection in kidney transplantation |
| Q42552348 | The short-term impact of protocol biopsies in a live-related renal transplant program using tacrolimus based immunosuppression |
| Q47279193 | The utility of surveillance biopsies in pediatric kidney transplantation |
| Q37624684 | Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview |
| Q37626743 | Urinary cell mRNA profiles predictive of human kidney allograft status |
| Q35250639 | Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection |
| Q82955043 | Usefulness of 3-month protocol biopsy of kidney allograft to detect subclinical rejection under triple immunosuppression with basiliximab: a single center experience |
Search more.